These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8522026)

  • 1. [Use of hydroxy-propyl-methyl cellulose (methocel) and carboxy-methyl cellulose containing artificial saliva in the symptomatic treatment of xerostomia].
    Nagy G; Olveti E; Zeher M; Márton S; Keszthelyi G
    Fogorv Sz; 1995 Sep; 88(9):299-304. PubMed ID: 8522026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of the rheological properties of artificial saliva types based on hydroxy-propyl-methyl-cellulose (methocel) and carboxy-methyl-cellulose (CMC)].
    Olveti E; Nagy G; Keszthelyi G
    Fogorv Sz; 1992 Feb; 85(2):57-62. PubMed ID: 1568511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of carboxymethylcellulose (CMC)-based artificial saliva in patients with xerostomia.
    Oh DJ; Lee JY; Kim YK; Kho HS
    Int J Oral Maxillofac Surg; 2008 Nov; 37(11):1027-31. PubMed ID: 18640823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
    Rhodus NL; Bereuter J
    J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind crossover trial of CMC- and mucin-containing saliva substitutes.
    Visch LL; Gravenmade EJ; Schaub RM; Van Putten WL; Vissink A
    Int J Oral Maxillofac Surg; 1986 Aug; 15(4):395-400. PubMed ID: 3091718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effect of the linseed extract Salinum and a methyl cellulose preparation on the symptoms of dry mouth.
    Andersson G; Johansson G; Attström R; Edwardsson S; Glantz PO; Larsson K
    Gerodontology; 1995 Jul; 12(1):12-7. PubMed ID: 8626174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Saliment on parotid salivary gland secretion and on xerostomia caused by Sjögren's syndrome.
    Donatsky O; Johnsen T; Holmstrup P; Bertram U
    Scand J Dent Res; 1982 Apr; 90(2):157-62. PubMed ID: 7041242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taste function in xerostomia before and after treatment with a saliva substitute containing carboxymethylcellulose.
    Temmel AF; Quint C; Schickinger-Fischer B; Hummel T
    J Otolaryngol; 2005 Apr; 34(2):116-20. PubMed ID: 16076410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and clinical evaluation of a high viscosity saliva substitute.
    van der Bijl P; de Waal J
    J Dent Assoc S Afr; 1994 Jun; 49(6):299-303. PubMed ID: 9508950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitated saliva secretion and reduced oral inflammation by a novel artificial saliva system in the treatment of salivary hypofunction.
    Kang M; Park H; Jun JH; Son M; Kang MJ
    Drug Des Devel Ther; 2017; 11():185-191. PubMed ID: 28138222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective and subjective efficacy of saliva substitutes containing mucin and carboxymethylcellulose.
    Olsson H; Axéll T
    Scand J Dent Res; 1991 Aug; 99(4):316-9. PubMed ID: 1771378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical comparative trial of saliva substitutes in radiation-induced salivary gland hypofunction.
    Epstein JB; Stevenson-Moore P
    Spec Care Dentist; 1992; 12(1):21-3. PubMed ID: 10895735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial saliva products and drugs to treat xerostomia.
    Wynn RL; Meiller TF
    Gen Dent; 2000; 48(6):630-6. PubMed ID: 12004654
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical comparison between commercially available mucin- and CMC-containing saliva substitutes.
    Vissink A; s-Gravenmade EJ; Panders AK; Vermey A; Petersen JK; Visch LL; Schaub RM
    Int J Oral Surg; 1983 Aug; 12(4):232-8. PubMed ID: 6418670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral mucous membrane flora in patients using saliva substitutes.
    Johansson G; Andersson G; Attstöm R; Edwardsson S
    Gerodontology; 2000 Dec; 17(2):87-90. PubMed ID: 11808059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of a saliva substitute as treatment for xerostomia in Sjögren's syndrome--a case report.
    Weisz AS
    Oral Surg Oral Med Oral Pathol; 1981 Oct; 52(4):384-6. PubMed ID: 6946360
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimizing dry mouth treatment for individuals with Sjögren's syndrome.
    Wu AJ
    Rheum Dis Clin North Am; 2008 Nov; 34(4):1001-10, x. PubMed ID: 18984418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing Moi-Stir to lemon-glycerin swabs.
    Poland JM; Dugan M; Parashos P; Irick N; Dugan W; Tracey M
    Am J Nurs; 1987 Apr; 87(4):422, 424. PubMed ID: 3551614
    [No Abstract]   [Full Text] [Related]  

  • 19. Xerostomia/Salivary Gland Hypofunction: Diagnosis and Management.
    Zunt SL
    Compend Contin Educ Dent; 2018 Jun; 39(6):365-369; quiz 371. PubMed ID: 29847962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical trial of a novel emulsion for potential use as a saliva substitute in patients with radiation-induced xerostomia.
    Apperley O; Medlicott N; Rich A; Hanning S; Huckabee ML
    J Oral Rehabil; 2017 Nov; 44(11):889-895. PubMed ID: 28741683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.